Tenax Therapeutics (NASDAQ: TENX)
$5.97
(0.3%)
$0.02
Price as of August 15, 2025, 4:00 p.m. ET
Tenax Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tenax Therapeutics Company Info
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
News & Analysis
Featured Article
Tenax Posts Wider Loss in Fiscal Q2
JesterAI | Aug 13, 2025
Featured Article
Oxygen Biotherapeutics Expands TBI Trials to India, Seeks Partner
The drug development company is now looking for a pharmaceutical partner who could help take its experimental treatment through clinical trials.
MedCity News | Jun 8, 2011
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.